Format

Send to

Choose Destination
Gut. 2019 Apr;68(4):765-767. doi: 10.1136/gutjnl-2018-316371. Epub 2018 Apr 16.

Proton pump inhibitors and risk of gastric cancer in a case-control study.

Lai SW#1,2, Lai HC#3,4, Lin CL1,5, Liao KF6,7.

Author information

1
College of Medicine, China Medical University, Taichung, Taiwan.
2
Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan.
3
College of Chinese Medicine, China Medical University, Taichung, Taiwan.
4
Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
5
Management Office for Health Data, China Medical University, Taichung, Taiwan.
6
College of Medicine, Tzu Chi University, Hualien, Taiwan.
7
Division of Hepatogastroenterology, Department of Internal Medicine, Taichung Tzu Chi General Hospital, Taichung, Taiwan.
#
Contributed equally

KEYWORDS:

case-control; gastric cancer; proton pump inhibitors

PMID:
29661803
DOI:
10.1136/gutjnl-2018-316371
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center